SBC Medical Group Holdings Inc

SBC remains in a Stage 4 decline with persistent lower highs and lower lows and price trading below all major EMAs. The medium-term bias is bearish, as the active Post-Capitulation pattern signals only exhaustion without structural repair. Extreme oversold conditions counsel caution, so execution will focus on trimming into rallies toward the 9/20 EMA resistance zone.

• ↑Underlying revenue +111% YoY and EBITDA +117% YoY ex-fee changes
• ↑72% repeat customer rate bolstered by multi-brand segmentation
• ↓Total revenue fell 9% YoY in Q1 due to fee structure revisions